NCT01362400 2014-05-19A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerInfinity Pharmaceuticals, Inc.Phase 2 Completed226 enrolled
NCT01497041 2011-12-22A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentKorean South West Oncology GroupPhase 2 Unknown35 enrolled